| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2003;108:3000.)
© 2003 American Heart Association, Inc.
Clinical Investigation and Reports |
From Service dAnatomie-Pathologie (A.T., L.C. D. Meyronnet, F.T., R.L.), Service de Cardiologie et Soins Intensifs (P.C.), and Service de Cardiologie Pédiatrique (P.B.), Hôpital Louis Pradel, Hospices Civils de Lyon, and the Institut de Médecine Légale (A.M., D. Malicier) and CNRS FRE 2692 (P.B.), Faculté de Médecine, Université Claude Bernard Lyon 1, Lyon, France.
Correspondence to Dr Patrice Bouvagnet, Service de Cardiologie Pédiatrique, Hôpital Louis Pradel, BP Lyon Montchat, 69394 Lyon Cedex 03, France. E-mail Patrice.Bouvagnet{at}chu-lyon.fr
Received July 24, 2003; revision received October 1, 2003; accepted October 5, 2003.
| Abstract |
|---|
|
|
|---|
Methods and Results We reviewed 14 000 forensic autopsies required by judicial authorities from January 1980 to January 1999 in a 2 000 000-resident area. Age, gender, and circumstances of death were recorded. Hearts were examined macroscopically and microscopically. In this series, the ARVC/D group accounted for 200 consecutive cases (10.4%) of USCD, including 108 males and 92 females (average age 32.5 and 34.5 years, respectively). Nearly one third of deaths occurred during the fourth decade of life. Circumstances of death were various, but 75.6% occurred during everyday life events (at home, 63.1%; in the street, 6.6%; or at work, 6.1%); only 7 cases (3.5%) occurred during sports activity. Nineteen cases (9.5%) happened during the perioperative period. Adipose infiltration of the right ventricle was either isolated (20%) or associated with fibrosis (74.5%) and lymphocytes (5.5%). A total of 14.5% of cases had cardiac hypertrophy, assessed by an increase in heart weight and/or left ventricular wall thickness. In most cases, the His bundle and its branches were abnormal either because of infiltration of adipose tissue (8.1%), fibrosis (54.3%), or both (5.6%).
Conclusions In ARVC/D, both sexes are equally affected, and there is a peak of risk during the fourth decade. Death most frequently occurs during sedentary activity. His abnormalities and left ventricular hypertrophy may be associated with ARVC/D.
Key Words: cardiomyopathy death, sudden tissue
| Introduction |
|---|
|
|
|---|
The phenotype of ARVC/D is highly variable, including ventricular tachycardia, supraventricular arrhythmias, right-heart failure, or asymptomatic presentations, but all too often the first and only symptom is sudden death.4,5 Because of the subtlety of the clinical phenotype, consensus criteria were developed on the basis of structural, functional, and electrocardiographic manifestations.6 ARVC/D prevalence has been estimated to be 1 in 5000.7 Family-related cases account for 30% to nearly 50% of all cases.68 In a particular instance, ARVC/D was demonstrated as being autosomal recessive and associated with noncardiac signs. In this ARVC/D form, the mutated gene coded for an essential component of desmosomes. In
30% of cases, ARVC/D is autosomal dominant.7 Eight chromosomal loci have been mapped, but only 2 genes have been identified to date (for a review, see Paul et al9).
Despite this recent progress, there are many unanswered questions. Is the high prevalence of ARVC/D in young athletes10,11 true for the general population? What is the relationship between fibrofatty replacement of the RV free wall and His bundle and left ventricular (LV) anomalies? Here, we report on a 20-year retrospective study of 200 sudden death cases related to ARVC/D by autopsy findings. In fact, the circumstances of death were diverse, and death usually occurred during everyday life events. Autopsy findings showed that specific RV wall abnormalities were associated primarily with His bundle and LV abnormalities.
| Methods |
|---|
|
|
|---|
Gross and Microscopic Examination of Heart-Lung Blocks
Heart-lung block gross (nonformalin-fixed) and microscopic examinations were performed as described previously.12,13 The heart weight and wall thickness of the LV and RV were recorded. A gross examination of coronary arteries, valves, walls, and cardiac chambers was performed that included transillumination with a source of light introduced inside the RV chamber (Figure 1A). The heart was then sectioned in slices of
1 cm from the apex to the base, the plane of the section being perpendicular to the long axis of the heart. LV free wall thickness was measured away from the papillary muscle. Ventricular and septal walls were examined carefully, and blocks of the anterior and posterior free wall of the LV, RV, and interventricular septum were removed systematically for histopathologic study. Specimens were also taken from any gross abnormality. In this way, the sites of the so-called triangle of dysplasia were scrutinized for myocardial replacement. Finally, the upper portion of the ventricular septum was excised and sectioned to analyzed the His bundle and its branches. Altogether, 15 to 20 samples were examined in each heart. Tissue samples were stained with hematein-phloxine-safran, a method that stains fibrous tissue in golden yellow, cardiomyocytes in red, and nuclei in dark blue (method available on request to A.T.). ARVC/D diagnosis was made according to several morphological criteria.1,6,1416 Diagnosis was based on myocardium absence between epicardial and endocardial layers in areas of the RV wall assessed by transillumination with a source of light introduced inside the RV chamber (Figure 1A) and by microscopic examination (Figure 1C). Epicardium and endocardium either joined up side by side or were separated by adult fatty tissue that sometimes contained sparse isolated myocardial cells or strongly disorganized clusters of myocardial cells trapped in fibrous tissue, including degenerating myocytes. Residual myocardium could be seen forming a subendocardial layer and in the trabeculae of the RV. Other microscopic anomalies could be noted, such as abnormal nuclei or a few lymphocytes in focal inflammation infiltrates. Partial wall replacement by fatty tissue alone was not included in this series if myocardial cells were not disorganized or isolated, because we considered these cases not to be ARVC/D but rather adipose infiltration.
|
Statistical Analysis
Continuous data are expressed as mean±SD. The Student t test was used to assess the significance of differences between 2 percentages. The
2 test was used to assess the significance of differences between subgroups. The general linear model of SPSS statistical software (SPSS, Inc) was used for univariate ANOVA. A probability value of less than 0.05 was considered statistically significant.
| Results |
|---|
|
|
|---|
Age and Gender
The group of 200 patients in whom ARVC/D was the only evidenced cause of death consisted of 108 males (5 to 57 years old, average 32.5±12.4 years) and 92 females (10 to 65 years old, average 35.5±12.0 years; P<0.08). Both sexes were equally exposed to sudden death, and there was no age difference at death. As shown in Figure 2, there was a gradual increase of death until the late 30s, followed by a progressive decrease, so that 30% of the cases died during the fourth decade of life. Among the 4 children younger than 11 years of age, only 1 was a girl, and the youngest child was a 5-year-old boy.
|
Circumstances of Death
Circumstances of death were classified as follows: (1) at home (with or without witness), (2) during work, (3) during sports exercise, (4) in a street or another public location, or (5) under a particular circumstance. In 2 instances (1 female and 1 male), the circumstances of death could not be retrieved. The distribution of circumstances of death is presented in Figure 3. In most cases, death occurred during daily activity either at home, at work, or in the street, because 150 (75.8%) of 198 died in such circumstances. Overall, death at home accounted for 125 cases (63.1%). By contrast, only 4 females and 3 males died during physical exercise (3.5%). One male and 1 female were swimming and drowned. Other sports involved were jogging (n=3), tennis (n=1), boxing (n=1), and soccer (n=1). The age of subjects who died during exercise was less than the age of the rest of the group (23.0±11.2 versus 34.3±12.2 years, respectively; P<0.017). Only 6 cases had arrhythmic disorders recorded before death: 3 ventricular fibrillation, 1 ventricular tachycardia, and 1 auriculoventricular block.
|
In 19 patients, death was related to surgery, which occurred during the perioperative period (10 males, 9 females; average age 35.4±16.5 years). In all cases, surgery was performed for minor lesions (eg, appendectomy, epistaxis, and cesarean section) either emergently (n=8) or scheduled (n=11) in patients with no cardiac history. Death occurred during anesthesia induction (n=4), during surgery (n=12), and up to 2 hours after surgery (n=3). Twenty-two patients died after a stressful or a specific event: minor car accident without visible injury or trauma (n=6), a fall in the street without injury (n=3), police arrest after a fight between young adults (n=1) or car theft (n=1), medical visit in a primary care physician or radiologists office (n=4), childbirth (n=2), hospitalization for suicide attempt with drugs using nonlethal doses (n=3), and influenza convalescence (n=2).
Macroscopic Observations
Lesion localization and extent were analyzed by transillumination (Figure 1A) and macroscopic study (Figure 1B). In most cases, lesions were located in the RV anterior wall in the mid portion along the interventricular groove. After both ventricles were sectioned on the level of the mid portion of the interventricular groove in a plane perpendicular to the long axis of ventricles, 3 patterns were observed in the RV circumference: (1) minor forms restricted to the 2- to 4-cm juxtaseptal anterior wall (40% of cases); (2) mild forms extended from the anterior interventricular groove to the RV edge (35% of cases); and (3) major forms with cavity dilatation, which spared only 3 to 4 cm of the RV posterior juxtaseptal area (23% of cases). In just 2% of cases, lesions were limited to the RV external edge.
Females and males more than 19 years of age had a mean heart weight of 311.4±66.4 and 365.3±74.8 g, respectively (P<0.00007). Although mean heart weight was normal for both sexes, the distribution of weight was abnormally wide, as shown in Figure 4. In females, 11 hearts weighed <240 g and 6 hearts weighed
430 g. Similarly, the dispersion of heart weight in males was wide, with 13 hearts weighing <280 g and 8 hearts weighing
480 g. It can be seen from Figure 4 that heart weight distribution appears to depart from a gaussian distribution.
|
The mean LV wall thickness values in females and males above the age of 19 years were 10.3±1.7 and 11.8±2.2 mm, respectively (P<0.0001). Among adults, 3 and 12 had a LV wall thickness
14 mm (females) and
15 mm (males), respectively (Figure 5). Altogether, 6 (7.3%) of 82 adult females and 13 (14.1%) of 92 adult males had either an increased heart weight or an increased LV wall thickness or both, fulfilling criteria for cardiac hypertrophy. In individuals aged between 1 and 19 years of age, 10 of 26 had the criteria for hypertrophy according to age-related normal values as assessed by heart weight and/or LV wall thickness17 (Table).
|
|
In conclusion, in children as well as in adults, ARVC/D was associated with LV hypertrophy in 14.5% of the cases (29/200). There was no difference in gender or age at death between hypertrophied and nonhypertrophied ARVC.
Microscopic Observations
Right Ventricle
The main lesion consisted of myocardial disappearance, either complete or with some remaining small islets of myocardial cells. Various aspects were observed in the fatty tissue replacing the myocardium. Adipose infiltration was rarely seen alone (40 of 200 cases, 20%). More frequently (149 of 200 cases, 74.5%), adipose replacement was associated with fibrosis. This fibrosis, which could be observed in the remaining disorganized myocardial cells, was either finely interstitial (127 of 200, 63.5%) or, much more rarely, made prominent mutilating blocks (11 cases, 5.5%). Myocardial cells that were trapped in this fibrous tissue showed signs of degeneration (intracytoplasmic vacuoles and myofibrillar loss). In 11 additional cases (5.5%), fibrosis extended to the vessels and the pericardium. Finally, in a few cases (n=11, 5.5%), the abnormal area was infiltrated by rare isolated lymphocytes. No difference was found in age, gender, circumstances of death, heart weight, LV posterior wall thickness, or LV histological involvement between these groups of RV histological abnormalities (adipose alone, adipose with fibrosis, and adipose with lymphocyte infiltration). The endocardium layer was often thickened by fibrosis, but papillary muscles always remained normal.
His and Bundle-Branch Observations
Histological examination of the His bundle and its 2 branches enabled us to obtain results from 197 cases. In 63 cases (32%), no alteration was evidenced. In the remaining 134 cases (68%), conductive tissue was infiltrated by fibrosis only (107 cases, 54.3%; Figure 1D), adipose tissue only (16 cases, 8.1%), or adipose tissue and fibrosis (11 cases, 5.6%; Figure 1E). These 2 latter groups were pooled to compare distribution between males and females. There was no difference (
2=0.45, P<0.798). Whereas in the right myocardium, the largest group had adipose tissue with fibrosis (74.5%), in the His bundle, the largest group had isolated fibrosis (54.3%). However, the group of isolated adipose tissue in the myocardium did not match the group of adipose tissue only in the His bundle. By comparison to these cases with ARVC/D, His and bundle branches of a group of 184 subjects with pulmonary causes of death (inhalation or acute and massive pulmonary infection) who were analyzed systematically showed an infiltration with adipose tissue, fibrosis, or both in fewer than 5% of the cases.
Left Ventricle
The LV was microscopically normal in 137 cases (68.5%). The most frequent anomaly was fibrosis (68 cases [34%]: interstitial [29 cases], perivascular [30], endocardial [9], or combined). Adipose tissue in the LV was rare, and its extent was limited to either the subepicardial area (8 cases) or the perivascular region associated with fibrosis (30 cases). Only 2 cases had lesions of myocarditis. LV histological involvement was not associated with age but was strongly associated with a greater heart weight (369.2±98.9 versus 312±64.6 g, P<0.001), a greater LV posterior wall thickness (12.4±2.3 versus 10.5±1.7 mm, P<0.001), and gender (36.1% males and 24.3% females with LV histological involvement, P<0.01). Only LV posterior wall thickness persisted as an independent factor of LV involvement.
| Discussion |
|---|
|
|
|---|
By contrast, it was a surprise to note that
10% of USCDs associated with ARVC/D occurred during the perioperative period. This suggests that patients with ARVC/D might be difficult to resuscitate after a cardiac arrest, because patients were within a medical environment when they had cardiac arrhythmias, a situation that is relatively more favorable than the other circumstances noted. It could also suggest that some anesthetic drugs might trigger arrhythmias in untreated ARVC/D patients.
Despite a predominant impact on the RV, ARVC/D anomalies also extend to other structures of the heart; in particular, the LV might be involved, as reported previously.20,21 LV hypertrophy is strongly associated with LV fibrosis infiltration but not with fibrofatty replacement of the RV. LV involvement appeared to be more prevalent in children than in adults in the present study, but we could not relate LV dimensions to body weight and height because these parameters were not recorded. The His bundle and its branches (but neither the sinus nor the AV node) were examined systematically, and it was observed that the disease very often extended to conduction bundles (68%) with fibrous (54.3%), adipose (8.1%), or fibrofatty (5.6%) infiltration. His bundle anomalies have thus far been overlooked because it was presumed that ARVC/D individuals were dying of lethal arrhythmias that arose from the RV free wall. The fact that two thirds of USCDs associated with ARVC/D have His anomalies suggests that conduction anomalies and/or arrhythmias arising from the conductive tissue might be responsible for some deaths. Among the rare cases in which cardiac activity could be recorded in the present study, 1 had a complete auriculoventricular block.
The histological criteria to ascertain ARVC/D are controversial. There is agreement on the fibrofatty variant, but the adipose variant is considered by some authors as normal22 and by others as pathological.23 We consider that isolated adiposis infiltration is pathological if it is associated with disorganized strands of myocytes that might be isolated. We did not find any association between a particular parameter and the adipose type alone or the adipose and fibrous subsets, which suggests that if there are 2 different entities, both lead to sudden cardiac death in similar conditions. The prevalence of inflammation varies widely in different studies from 2%15 to 79%21 compared with 5.5% in the present report and 19% in another.19 Inflammation is not a cause of ARVC/D but rather an aggravating factor.
| Acknowledgments |
|---|
| References |
|---|
|
|
|---|
2. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation. 1982; 65: 384398.
3. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation. 1996; 93: 841842.
4. Nava A, Scognamiglio R, Thiene G, et al. A polymorphic form of familial arrhythmogenic right ventricular dysplasia. Am J Cardiol. 1987; 59: 14051409.[CrossRef][Medline] [Order article via Infotrieve]
5. Fontaine G, Fontaliran F, Hebert JL. Arrhythmogenic right ventricular dysplasia. Annu Rev Med. 1999; 50: 1735.[CrossRef][Medline] [Order article via Infotrieve]
6. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy: Task Force of the Working Group on Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J. 1994; 71: 215218.
7. Thiene G, Basso C, Danieli G, et al. Arrhythmogenic right ventricular cardiomyopathy. Trends Cardiovasc Med. 1997; 7: 8490.
8. Hamid S, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol. 2002; 40: 14451450.
9. Paul M, Schulze-Bahr E, Breithardt G, et al. Genetics of arrhythmogenic right ventricular cardiomyopathy: status quo and future perspectives. Z Kardiol. 2003; 92: 128136.[CrossRef][Medline] [Order article via Infotrieve]
10. Thiene G, Nava A, Corrado D, et al. Right ventricular cardiomyopathy and sudden death in young people. N Engl J Med. 1988; 318: 129133.[Abstract]
11. Corrado D, Basso C, Thiene G. Sudden cardiac death in young people with apparently normal heart. Cardiovasc Res. 2001; 50: 399408.
12. Davies MJ, Pomerance A, Lamb D. Techniques in examination and anatomy of the heart. In: Pomerance A, Davies MJ, eds. The Pathology of the Heart. Oxford, UK: Blackwell Scientific Publications; 1975: 148.
13. Tabib A, Miras A, Tanier P, et al. Undetected cardiac lesions cause unexpected sudden cardiac death during occasional sport activity: a report on 80 cases. Eur Heart J. 1999; 20: 900903.
14. Rossi P, Massumi A, Gillette P, et al. Arrhythmogenic right ventricular dysplasia: clinical features, diagnostic techniques, and current management. Am Heart J. 1982; 103: 415420.[CrossRef][Medline] [Order article via Infotrieve]
15. Tabib A, Loire R. Etude anatomo-clinique de 100 cas dhypoplasie du muscle ventriculaire droit (dont 89 morts subites inattendues). Parenté avec lanomalie d Uhl. Arch Mal Coeur. 1992; 85: 17891795.[Medline] [Order article via Infotrieve]
16. Fontaine G, Fontaliran F, Frank R, et al. Arrhythmogenic right ventricular dysplasia: a new clinical entity. Bull Acad Natl Med. 1993; 177: 501512.[Medline] [Order article via Infotrieve]
17. Scholz DG, Kitzman DW, Hagen PT, et al. Age-related changes in normal human hearts during the first 10 decades of life: part I (growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old. Mayo Clin Proc. 1988; 63: 126136.[Medline] [Order article via Infotrieve]
18. Shen WK, Edwards WD, Hammill SC, et al. Sudden unexpected nontraumatic death in 54 young adults: a 30-year population-based study. Am J Cardiol. 1995; 76: 148152.[CrossRef][Medline] [Order article via Infotrieve]
19. Corrado D, Thiene G, Nava A, et al. Sudden death in young competitive athletes: clinicopathologic correlations in 22 cases. Am J Med. 1990; 89: 588596.[CrossRef][Medline] [Order article via Infotrieve]
20. Fontaliran F, Fontaine G, Filette F, et al. Frontières nosologiques de la dysplasie arythmogène. Variations quantitatives du tissu adipeux ventriculaire droit normal. Arch Mal Coeur. 1991; 84: 3338.
21. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol. 1997; 30: 15121520.[Abstract]
22. Burke AP, Farb A, Tashko G, et al. Arrhythmogenic right ventricular cardiomyopathy and fatty replacement of the right ventricular myocardium. Are they different? Circulation. 1998; 97: 15711580.
23. DAmati G, Leone O, Tizian di Gioia CR, et al. Arrhythmogenic right ventricular cardiomyopathy: clinicopathologic correlation based on a revised definition of pathologic patterns. Hum Pathol. 2001; 32: 10781086.[CrossRef][Medline] [Order article via Infotrieve]
This article has been cited by other articles:
![]() |
S V de Noronha, S Sharma, M Papadakis, S Desai, G Whyte, and M N Sheppard Aetiology of sudden cardiac death in athletes in the United Kingdom: a pathological study Heart, September 1, 2009; 95(17): 1409 - 1414. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. C. Garcia, V. Bazan, E. S. Zado, J.-F. Ren, and F. E. Marchlinski Epicardial Substrate and Outcome With Epicardial Ablation of Ventricular Tachycardia in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia Circulation, August 4, 2009; 120(5): 366 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Ozben, I. Altun, V. Sabri Hancer, A. K. Bilge, A. M. Tanrikulu, R. Diz-Kucukkaya, A. S. Fak, E. Yilmaz, and K. Adalet Angiotensin-converting enzyme gene polymorphism in arrhythmogenic right ventricular dysplasia: is DD genotype helpful in predicting syncope risk? Journal of Renin-Angiotensin-Aldosterone System, December 1, 2008; 9(4): 215 - 220. [Abstract] [PDF] |
||||
![]() |
S. Peters Arrhythmogenic right ventricular dysplasia-cardiomyopathy and provocable coved-type ST-segment elevation in right precordial leads: clues from long-term follow-up Europace, July 1, 2008; 10(7): 816 - 820. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Stephenson and C. I. Berul Electrophysiological Interventions for Inherited Arrhythmia Syndromes Circulation, August 28, 2007; 116(9): 1062 - 1080. [Full Text] [PDF] |
||||
![]() |
D. Dalal, R. Jain, H. Tandri, J. Dong, S. M. Eid, K. Prakasa, C. Tichnell, C. James, T. Abraham, S. D. Russell, et al. Long-Term Efficacy of Catheter Ablation of Ventricular Tachycardia in Patients With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., July 31, 2007; 50(5): 432 - 440. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Kirchhof, L. Fabritz, M. Zwiener, H. Witt, M. Schafers, S. Zellerhoff, M. Paul, T. Athai, K.-H. Hiller, H. A. Baba, et al. Age- and Training-Dependent Development of Arrhythmogenic Right Ventricular Cardiomyopathy in Heterozygous Plakoglobin-Deficient Mice Circulation, October 24, 2006; 114(17): 1799 - 1806. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dalal, C. James, R. Devanagondi, C. Tichnell, A. Tucker, K. Prakasa, P. J. Spevak, D. A. Bluemke, T. Abraham, S. D. Russell, et al. Penetrance of Mutations in Plakophilin-2 Among Families With Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy J. Am. Coll. Cardiol., October 3, 2006; 48(7): 1416 - 1424. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. S. Duffy How Do Myocytes Tell Right From Left? Circ. Res., September 15, 2006; 99(6): 563 - 564. [Full Text] [PDF] |
||||
![]() |
D. A. Cesario and G. W. Dec Implantable Cardioverter- Defibrillator Therapy in Clinical Practice J. Am. Coll. Cardiol., April 18, 2006; 47(8): 1507 - 1517. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dalal, L. H. Molin, J. Piccini, C. Tichnell, C. James, C. Bomma, K. Prakasa, J. A. Towbin, F. I. Marcus, P. J. Spevak, et al. Clinical Features of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Associated With Mutations in Plakophilin-2 Circulation, April 4, 2006; 113(13): 1641 - 1649. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.P. van Tintelen, M. M. Entius, Z. A. Bhuiyan, R. Jongbloed, A. C.P. Wiesfeld, A. A.M. Wilde, J. van der Smagt, L. G. Boven, M. M.A.M. Mannens, I. M. van Langen, et al. Plakophilin-2 Mutations Are the Major Determinant of Familial Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circulation, April 4, 2006; 113(13): 1650 - 1658. [Abstract] [Full Text] [PDF] |
||||
![]() |
A Fabre and M N Sheppard Sudden adult death syndrome and other non-ischaemic causes of sudden cardiac death Heart, March 1, 2006; 92(3): 316 - 320. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Dalal, K. Nasir, C. Bomma, K. Prakasa, H. Tandri, J. Piccini, A. Roguin, C. Tichnell, C. James, S. D. Russell, et al. Arrhythmogenic Right Ventricular Dysplasia: A United States Experience Circulation, December 20, 2005; 112(25): 3823 - 3832. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Kanaan, K. Shamsuddin, M. Silka, and W. Wells Right ventricular outflow tract resection for treatment of refractory ventricular tachycardia in a 2-year-old child J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 948 - 949. [Full Text] [PDF] |
||||
![]() |
B. J. Maron, M. J. Ackerman, R. A. Nishimura, R. E. Pyeritz, J. A. Towbin, and J. E. Udelson Task Force 4: HCM and other cardiomyopathies, mitral valve prolapse, myocarditis, and Marfan syndrome J. Am. Coll. Cardiol., April 19, 2005; 45(8): 1340 - 1345. [Full Text] [PDF] |
||||
![]() |
J.-S. Hulot, X. Jouven, J.-P. Empana, R. Frank, and G. Fontaine Natural History and Risk Stratification of Arrhythmogenic Right Ventricular Dysplasia/Cardiomyopathy Circulation, October 5, 2004; 110(14): 1879 - 1884. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Fontaine, P. Fornes, A. Tabib, R. Loire, L. Chalabreysse, D. Meyronnet, A. Miras, D. Malicier, F. Thivolet, P. Chevalier, et al. Histology of Sudden Death in Arrhythmogenic Right Ventricular Cardiomyopathy/Dysplasia * Response Circulation, July 20, 2004; 110(3): e20 - e20. [Full Text] [PDF] |
||||
![]() |
D. P. Zipes The year in electrophysiology J. Am. Coll. Cardiol., April 7, 2004; 43(7): 1306 - 1314. [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2003 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |